「no」の検索結果
164件：16～20件目を表示
-
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
uble-Masked, Placebo-Controlled Phase 3 Pivotal Study – Yuichi Hori, MD, PhD; Tomoyuki Wada, PhD; Minoru Kanamoto, MSc; Kazunori Omatsu, BSc AAO 2025 開催日：2025年10月17日～2025年10月20日 開催地：Orlando, FL, USA M...
https://www.senju.co.jp/english/rd/society/ -
July 16, 2024 General Announcement: Senju Pharmaceutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Senju has successfully completed Phase III clinical trials in Japan for the novel Dry Eye Disease tr...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716.pdf -
Production | About Senju | SENJU Pharmaceutical
tical, are being produced in the plant in an advanced production environment using cutting-edge technology and are being delivered throughout Japan and worldwide. Production base Manufacturing Plant F...
https://www.senju.co.jp/english/about/production.html -
R&D Pipeline | Research & Development | SENJU Pharmaceutica
suring of information after Phase 1 DrugIndicationStatus (Region) SJP-0132Dry eyeApproval（Japan） PranoprofeninflammationApplication under review (Vietnam) SJP-0132Dry eyeP3（China） SJP-0008Central Reti...
https://www.senju.co.jp/english/rd/pipeline.html -
Company Profile | About Senju | SENJU Pharmaceutical
Corporate Name Senju Pharmaceutical Co.,Ltd. Headquarter 3-1-9, Kawara-machi, Chuo-ku, Osaka 541-0048,Japan TEL：+81-6-6201-2512 FAX：+81-6-6226-0406 Date of Incorporation April 9, 1947 Capital 1,415,50
http://www.senju.co.jp/english/about/outline.html